A Trial to Investigate Safety, Exposure, and Efficacy of HU6 Compared With Placebo in Adult Participants With Metabolic Dysfunction-associated Steatohepatitis (MASH)

NCT07491458 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

180

Enrollment

INDUSTRY

Sponsor class

Conditions

MASH - Metabolic Dysfunction-Associated Steatohepatitis

Interventions

DRUG: HU6
OTHER: Placebo

Sponsor

Rivus Pharmaceuticals, Inc.